Orencia clickject 125 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26F0MC2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,683
Award facts
- Contract value 100% obligated
- $27,682.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,682.60 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, represents a task order executed under a larger indefinite delivery contract vehicle. The award was competitively awarded with no set-aside designation, demonstrating the contractor's ability to meet federal procurement requirements through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime contract vehicle serves as the comprehensive global pharmaceutical support mechanism enabling the delivery of a broad spectrum of pharmaceutical products and medical supplies to military healthcare programs worldwide. The DLA contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting critical medical procurement needs for the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0MC2?
SPE2DR26F0MC2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F0MC2 worth?
The government has obligated $27,683 on SPE2DR26F0MC2.
Is contract SPE2DR26F0MC2 an order under another contract?
Yes. SPE2DR26F0MC2 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0MC2 competed?
The extent of competition for SPE2DR26F0MC2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award